InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+29.4%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Bookman Michael, Directeur Juridique. Insider active across 1 company, notably Immuneering Corp. Aggregated, 4 disclosures have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €28k. Activity tracked since 3 August 2021. The latest transaction was disclosed on 1 October 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bookman Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
1,020 股@ US$6.829919.5% 占其流量Class A Common StockSEC:0001790340-25-000121:0
标准退出：2025年12月30日 (T+90)
1,448 股@ US$1.625.1% 占其流量Class A Common StockSEC:0001790340-24-000032:0
1,000 股@ US$4.8815.2% 占其流量Class A Common StockSEC:0001415889-22-005253:0
标准退出：2022年8月15日 (T+90)
1,402 股@ US$15.0058.2% 占其流量Class A Common StockSEC:0001104659-21-099728:0
标准退出：2021年11月1日 (T+90)
4 条申报中的 4 条
About Bookman Michael
Michael Bookman serves as the General Counsel and Secretary of Immuneering Corp. He is responsible for all legal matters of the company, ensuring regulatory compliance and protecting the legal interests of the organization. His expertise is essential for navigating the complex legal landscape.
